Showing results (181-190 of 283) with videos related to

Sort By:
Pageof 29
Gynecologic Oncology|October 2, 2012
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trialElisabeth Epstein, Antonia Testa, Adrius Gaurilcikas, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 21, 2016
European Society of Gynaecologic Oncology Quality Indicators for Advanced Ovarian Cancer SurgeryDenis Querleu, François Planchamp, Luis Chiva, et al.
International Journal of Cancer|October 20, 2023
Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trialChiara Herzog, Allison Jones, Iona Evans, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial designIgnace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|May 27, 2023
Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genesNikola Hájková, Michaela Kendall Bártů, David Cibula, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 16, 2024
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial designIgnace Vergote, Alejandro Perez Fidalgo, Giorgio Valabrega, et al.
Cancers|June 2, 2021
Lower-Limb Lymphedema after Sentinel Lymph Node Biopsy in Cervical Cancer PatientsDavid Cibula, Martina Borčinová, Simone Marnitz, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 6, 2022
Ten years of live surgical broadcast at Charité-MAYO conferences (2010-2019): a systematic evaluation of the surgical outcomeJudith Altmann, Radoslav Chekerov, Christina Fotopoulou, et al.
Gynecologic Oncology|October 8, 2024
The prognosis of stage IA cervical cancer: Subgroup analysis of the SCCAN studyZheng Yuan Ng, Ranjit Manchanda, Aldo Lopez, et al.
Nature Cancer|July 4, 2025
Sentinel lymph node biopsy without systematic pelvic lymphadenectomy in females with early-stage cervical cancer: final outcome of the SENTIX prospective, single-arm, noninferiority, international trialDavid Cibula, Simone Marnitz, Jiří Jarkovský, et al.
Pageof 29